Joe Tartaglia CEO |
Liam O Neill CTO |
John O Donoghue Executive |
Mike Fourkas VP R&D |
Denis O Sullivan Biomedical Engineer |
Cian Madigan Mechanical Engineer |
PETER MILNER MD Cardiologist. CEO of Heart Metabolics. CEO, AshHill Pharmaceutical Investments. Founder, Optivia Biotechnology. SAB, Novartis Biomedical Research. |
MICHAEL MARTIN MD Assoc Professor, UCSF Dept of Epidemiology and Biostatistics. Variety of medial executive positions. |
PAUL AUERBACH MD Prof of Surgery and Chief of Div of Emergency Medicine, Stanford University. CMO of Healthline Networks. Former VC, Delphi Ventures, COO of Sterling Healthcare Group. |
TED McCLUSKEY MD/PhD Interventional Cardiologist, PhD Pharmacology. 20 years in Biotechnology industry. Former President Sand Hill Angels |
JEFFREY KAPLAN MD Medical Director at Good Samaritan Hospital wound care center and a board certified vascular surgeon. Advisor and investor for Medtech companies. |
TED TUSSING Venture Associate, TriVentures. Former Dir for Corporate New Ventures at Stanford Univ Medical Center. Director at BioCardia. |
M. CHRISTINE LEE MD Board-certified dermatologist and Asst Clinical Professor at UCSF. Specialist in Mohs micrographic surgery, skin cancer surgery and reconstruction. |